posted
Anybody have any opinions on this one? dardadog, I see you're on the prowl this morning. What do you think?
Walgreens Places Chain-Wide Order for Lifestream Technologies' Cholesterol Monitor
Distribution Now at 25,000 Quality Retail Outlets Nationwide with the Addition of Walgreens
POST FALLS, Idaho, Jun 1, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), a leading developer and marketer of consumer cholesterol monitors and professional screening instruments, announced today that Walgreen Co. (WAG) (WAG) has agreed to distribute the Lifestream Cholesterol Monitor at its retail locations nationwide. Walgreens is the largest drug store chain in the country with more than 4,400 pharmacies nationwide.
"By securing distribution at Walgreens, we continue to significantly broaden our availability and visibility to consumers nationwide," said President & CEO Christopher Maus. "We welcome Walgreens participation in providing its customers the ability to monitor their cholesterol, the major contributing factor in heart disease. Lifestream's goal is to provide accessible and affordable health monitoring solutions to consumers nationwide. Walgreens offers consumers quality health-related products in locations across the country."
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader, further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
The Lifestream Cholesterol Monitor is an affordable, handheld device which provides users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) smart card, allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
posted
CVS Begins Chain-Wide Script Attachment Program in 4,120 Stores
CVS Attaching a $15 Discount Coupon toward the Purchase of Lifestream's Home Cholesterol Monitor on All New Cholesterol Drug Prescriptions
POST FALLS, Idaho, May 26, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), a leading developer and marketer of consumer cholesterol monitors and professional screening instruments, announced today that CVS Corporation (CVS), one of the nation's leading drug store chains with over 4,100 stores, has started attaching a $15 discount coupon toward the purchase of Lifestream's Home Cholesterol Monitor on every new prescription for a cholesterol lowering drug.
"It is a well known fact that monitoring cholesterol at home increases adherence for the over 17 million individuals who are taking cholesterol lowering (statin) drugs. Today, with adherence at only 30%, we are targeting the statin user with an offer when they fill their prescription to get them to starting monitoring their progress," stated Christopher Maus, Lifestream's president and CEO. "During this collaborative relationship with CVS, thousands of users will be educated about the value of monitoring and receive a significant incentive to do so. We look forward to working with other chains to educate the health conscious consumer about the value of self monitoring when they seek to lower their cholesterol."
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
posted
Nice to see they're moving the product. I got in when I heard they got Rush Limbaugh as their spokesperson. I guess they should have gotten the GameznFlix dude instead...
Now that I think of it, who would want to be known as the Cholesterol Dude anyway?
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
posted
Just placed a nice order. With the ongoing news about obesity (THE #1 health problem in the US and growing), the AMA guidelines for management, and the Atkins diet, this stock is a no brainer. WAG has 4300 stores and growing daily.
Posts: 24 | From: Phoenix, AZ | Registered: Apr 2004
| IP: Logged |
posted
TUESDAY, JUNE 08, 2004 FDA Grants Clearance for New Diagnostic Technology; Lifestream Technologies Obtains 510k Clearance for Recently Patented Technology - BusinessWire 6:30 AM FALLS, Idaho--(BUSINESS WIRE)--June 8, 2004--Lifestream Technologies, Inc. (OTCBB:LFTC), a leading developer and marketer of consumer cholesterol monitors and professional screening instruments, announced today that it has received clearance from the FDA to sell its innovative cholesterol monitor incorporating the "Health Risk Assessment" to consumers. This revolutionary technology enables consumers to not only track cholesterol levels, but also calculate their personal risk of heart attack, obesity, etc.
The newly patented technology allows the user to obtain a full Health Risk Assessment after taking a three-minute total cholesterol test and inputting eight additional risk factors including: gender, age, height, weight, diabetic status, smoker/non-smoker, systolic and diastolic blood pressure, and HDL break-out from a recent lipid profile. The Health Risk Assessment (HRA) shows the user's risk of a heart attack if no changes are made to alter one's behavior or lifestyle. In addition, the monitor also allows the user to evaluate different outcome models by altering the inputs (i.e. smoker vs. non-smoker).
"Clearance by the FDA allows our innovative approach to home testing to bring new meaning for individuals seeking to take control of their heart health," said Christopher Maus, CEO of Lifestream Technologies. "Assessing numerous components related to heart health at one time takes home testing to a new level and gives individuals clear and meaningful information to support their efforts to change."
According to the former head of preventive cardiology at the Cleveland Clinic Foundation, Dennis L. Sprecher, M.D., feedback strategies have been particularly valuable in promoting compliance with personal health maintenance practices, such as exercise and diet, as well as careful daily use of medications.
"The Framingham Heart Study, National Institute of Health, NCEP, as well as other organizations, are increasing their focus more on total risk analysis, particularly regarding obesity, smoking, elevated cholesterol and blood pressure as an expression of heart health. We see our new technology well positioned to support the government's public health initiatives to get people to take control of their health," stated Jackson B. Connolly, vice president product development at Lifestream Technologies.
"The availability of this type of risk factor calculation brings home the impact of cholesterol on the overall risk of developing heart disease and gives patients the tools they need to see the impact of various lifestyle issues on the likelihood of developing heart problems. It also makes the activity of measuring cholesterol more relevant and meaningful," said Dr. Boyd Lyles, director of the Heart Health and Wellness Center in Dallas, TX.
Clearance by the FDA of the Lifestream "Health Risk Assessment" monitor is the result of a one-year evaluation of the scientific evidence supporting the safe and effective use of this monitor.
The monitor will be available to consumers in late June 2004 via www.knowitforlife.com or 1-888-954-LIFE (5433) and will be available through other distribution channels later this year. To request a product demonstration video feed, email gerriv@lifestreamtech.com.
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com
This news release includes certain forward-looking statements...
[This message has been edited by Allstocks (edited June 08, 2004).]
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
However, this is one that I may have to play long. With sales to WAG and CVS, this should be a winner. I work at WAG and I can tell you that I am asked several times weekly for this item.
[This message has been edited by Allstocks (edited June 08, 2004).]
Posts: 1885 | From: Tampa, FL, US | Registered: Mar 2004
| IP: Logged |
quote:Originally posted by DelightInFlight: Just placed a nice order. With the ongoing news about obesity (THE #1 health problem in the US and growing), the AMA guidelines for management, and the Atkins diet, this stock is a no brainer. WAG has 4300 stores and growing daily.
4400+ but who's counting! LOL..
Not to mention plans for 7000 stores by 2010, and mail order facilities... a new store every 17 hours right now... do the math folks... that's a huge order just to put 3 machines on every store shelf... even if they don't sell...
Posts: 1885 | From: Tampa, FL, US | Registered: Mar 2004
| IP: Logged |
posted
Yeah, they're even carried by Costco. That's not too shabby.
I just got something in the mail yesterday from the Subway, LFTC's new PR firm. It's a $50 rebate on a purchase of the Lifestream Plus Cholesterol Monitor and Total Cholesterol Test Packets. And it's just for shareholders (so it says). So if you want to get one, here it is:
posted
Hey thanks for pointing this out I got in today right at the bell and seeing a 4.5% increase already.
Posts: 163 | From: Colorado | Registered: Apr 2004
| IP: Logged |
posted
Well, they're not exactly selling diamonds, but we should all have our cholesterol checked. It would be nice to live long enough to enjoy our CMKX fortune.
"The newly patented technology allows the user to obtain a full Health Risk Assessment after taking a three-minute total cholesterol test and inputting eight additional risk factors including: gender, age, height, weight, diabetic status, smoker/non-smoker, systolic and diastolic blood pressure, and HDL break-out from a recent lipid profile."
If only they would add "daytrader" to the list of factors....
quote:Originally posted by premiumtodd: Hey thanks for pointing this out I got in today right at the bell and seeing a 4.5% increase already.
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
posted
TC Neil Luckianow to Head National Sales Team; Lifestream Technologies Acquires Extensive Sales & Marketing Experience with Former Amira and LifeScan Executive
June 16, 2004 06:30:00 (ET)
POST FALLS, Idaho, Jun 16, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC, Trade), a leading developer and marketer of consumer cholesterol monitors and professional screening instruments, announced today that Neil Luckianow has been retained to manage and direct its national sales force. Mr. Luckianow, a principal in NCL & Associates, LLC, brings an extensive background in sales and marketing from the glucose home diagnostic business.
Previously with Amira Medical/Mercury Diagnostics (Roche Diagnostics, Inc.) as Director of Sales, Mr. Luckianow was responsible for the creation and implementation of a health care professional call strategy. He also designed a product distribution strategy for the company's glucose monitoring product from first product entry until Roche Diagnostics acquired Amira. As Senior Director, National Sales, for Magic American Corporation, Mr. Luckianow developed strategic and tactical plans for a new line of home health care products and successfully launched the new product line into 6,000 plus retail outlets. Prior to Magic American, Mr. Luckianow held various sales and trade development positions with LifeScan, Inc., a Johnson and Johnson company, where he was responsible for retail sales, promotions and distribution channels for the company's glucose monitoring products.
"We are extremely pleased to be able to add Neil's experience to head our sales representative team," said Christopher Maus, Lifestream's President and Chief Executive Officer. "His extensive background in sales, marketing and general management for the consumer diagnostic markets can provide invaluable expertise to Lifestream as we continue to engage our marketing campaign and expand our presence on the retail shelf."
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
posted
Thanks to a caller named Paul, IBCRadio just got done talking about LFTC. Darren just read their official profile on the air. That can't hurt none.
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
POST FALLS, Idaho--(BUSINESS WIRE)--June 29, 2004--
Company demands to be delisted from the Berlin Stock Exchange
Lifestream Technologies, Inc. (OTCBB:LFTC), a leading developer and marketer of consumer cholesterol monitors and professional screening instruments, today released a letter to shareholders to address shareholder concern regarding the recent stock trading activity and share price of the Company's stock. The letter is distributed through this press release in its entirety.
Dear Fellow Shareholders:
I share everyone's disappointment in the recent share price decline. The Company has received a large number of emails and calls regarding this situation and it has been a challenge to return all the calls in a timely manner. Therefore, this communication is intended to address and assuage the concerns expressed in emails and over the phone.
The recent share price decline cannot be simply tied to any recent change in the Company's day-to-day operations since many consider the recent changes to be beneficial in nature. The Company is continuing operations according to its business strategy. With the addition of Walgreen's and the continuation of our awareness programs, we do not anticipate moving away from this strategy. We see nothing that accounts for the recent decline in market capitalization. In fact, operationally, the Company is in better shape today than 18 months ago.
We can only speculate as to any possible external cause for the share price decline. Lifestream recently became aware of the unauthorized listing on the Berlin-Bremen Stock Exchange. Many allegations have recently been discussed in the press regarding a possible arbitrage on U.S. markets leveraging stock that might not exist on the Berlin-Bremen Stock Exchange (BBSE). While these allegations have not been verified, the Company believes the potential downside of the exchange listing could be greater than any benefits being derived. As a result, the Company has sent written demand to the Berlin-Bremen Stock Exchange that it immediately cease trading in the Company's common stock and take whatever measures are necessary to completely delist the Company's common stock from the BBSE.
Our primary strategy to address the current share price decline is to stay on course and operationally grow the Company, building on the fundamentals of revenue growth and profitability. We are confident that, in time, our ongoing operational performance will overcome any external forces negatively impacting the Company's price per share.
Thank you for your ongoing support.
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R), allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties, and in particular statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results. The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed June 10, 2004, and in "Item 1 - Our Business," "Item 6 - Our Management's Discussion and Analysis," particularly the discussion under "Risk Factors - Substantial Doubt as to our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2003, both filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Form 10-KSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business. Contacts Lifestream Technologies, Inc. Gerri Vance, 208-457-9409, ext. 1221 (Investor Relations) gerriv@lifestreamtech.com
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
posted
Dont forget about this one guys... Recent request to de-list, PR's hinting at new news soon and close to 52 wk low..check it out...GLTA
Posts: 206 | From: silver spring, MD, USA | Registered: Feb 2004
| IP: Logged |
posted
Check out the vol. end of day...JEFF just dropped off the ask for the first time all day.
Posts: 206 | From: silver spring, MD, USA | Registered: Feb 2004
| IP: Logged |
Lifestream Technologies' Shipments Double in Fourth Quarter 2004; With additional distribution and increasing awareness, Lifestream sees its business expanding in 2005
POST FALLS, Idaho--(BUSINESS WIRE)--July 7, 2004--Lifestream Technologies(TM) (OTCBB:LFTC), the leading manufacturer of home cholesterol monitors and professional screening devices, today announced that shipments in the fourth quarter were twice that of the same quarter ending 2003. The addition of a new retail account contributed to this increase in shipments.
"With the addition of a major retailer and our recent advertising and promotional programs, we are looking forward to an improvement in sales numbers," said Christopher Maus, Lifestream President and CEO. "An important component of improving our cash position is better management of our inventory as our sales increase. We expect to see an improvement in performance over the coming quarters with continued strong orders, increased margins, and cost containment. We continue to aggressively pursue the remaining distribution channels through the addition of new retail accounts."
"Lifestream's revenue recognition policy does not necessarily result in revenue recognition at the time product is shipped and, therefore, shipments may not be an indicator of the revenue to be reported on our financial statements. This increase in shipments is, however, a good indicator of our success in increasing distribution and creating awareness of our cholesterol monitor with consumers," stated Nikki Nessan, VP Finance.
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
posted
Been waiting for this PR. Their consolidating near their 52wk low for quite some time now. I also expect a PR within the next week or so stating the sucessful de-listing from the BBSE. Also, their recent 10-Q mentioned consumer awareness test's to be concluded "end of June". Could be another PR....Great Long candidate IMO!! GLTA
Posts: 206 | From: silver spring, MD, USA | Registered: Feb 2004
| IP: Logged |
posted
There appears to be a wrinkle forming in regards to delisting from BBSE.
-Only companies that have no trading volume on the BBSE qualify for delisting, he said. If a company that trades actively were to be delisted, German investors who own the stock would not be able to sell their positions, he said.
quote:Originally posted by FurrySound: There appears to be a wrinkle forming in regards to delisting from BBSE.
-Only companies that have no trading volume on the BBSE qualify for delisting, he said. If a company that trades actively were to be delisted, German investors who own the stock would not be able to sell their positions, he said.
quote:Originally posted by BroBro: Been waiting for this PR. Their consolidating near their 52wk low for quite some time now. I also expect a PR within the next week or so stating the sucessful de-listing from the BBSE. Also, their recent 10-Q mentioned consumer awareness test's to be concluded "end of June". Could be another PR....Great Long candidate IMO!! GLTA
posted
I picked up around 30000 a week ago @ .026. I actually have been watching this company, waiting for the bottom, etc. I tried to e-mail the company yesterday but my email was returned?? It seems hard to reach someone... Also, their transfer agent's phone number posted on their website is about 5 yrs. outdated. I found the new phone number and called to verify that they were still the Transfer Agent and they were so no biggie there. I actually sold today though @ .034 expecting another oppurtunity to buy lower. We'll see... Hopefully im wrong for your guys sake...GLTA
[This message has been edited by BroBro (edited July 08, 2004).]
Posts: 206 | From: silver spring, MD, USA | Registered: Feb 2004
| IP: Logged |
posted
the monitor is now IN STOCK at Walgreens.... let's see this sucker fly now!
Posts: 1885 | From: Tampa, FL, US | Registered: Mar 2004
| IP: Logged |
Lifestream Technologies' Advertising and Promotion Programs Kick In; Lifestream Sees Expansion in 2005 as Advertising and Targeted Marketing Increase Sales 29%
POST FALLS, Idaho--(BUSINESS WIRE)--July 13, 2004--Lifestream Technologies, Inc. (OTCBB:LFTC), the leading manufacturer of home cholesterol monitors and professional screening devices, today announced that sales within a subset of its primary retail distribution channel are up 29% from the same period last year.
"With the implementation of our radio ad campaign beginning in March, as well as key promotional programs, Lifestream is realizing the preliminary impact of increasing consumer awareness for its products," noted Christopher Maus, Lifestream's President and CEO. "When compared to the same period last year, the subset's retail sales activity between mid March through mid May shows a 29% increase verifying that Lifestream's recent advertising and promotional activities are showing significant improvements within targeted retail segments. When compared with the subset's retail sales activity for January through mid March, Lifestream products realized a 19% increase. Generally, sales tend to flatten after the Christmas holiday, but continued retail sales increases reinforce the fact that Lifestream's efforts to raise awareness are having a material impact on retail growth."
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
posted
okay, I quit. I don't understand what the H**L is going on. I am so sick and tired of these stocks having great news and the stock trades sideways or goes down. These guys report a 29% increase in sales over the last quarter of last year plus and even larger increase in sales than last quarter when traditionally the sales are suppose to decline in the summer and what happens! The freak'n stock just sits there like nothing happend! Can someone please explain to me why this stock or CORR or TFCT or any of the other numerous stocks don't go up when they report good solid financial news. These are not fluff PRs either. I just don't understand
Posts: 1006 | From: Camp Hill, PA, USA | Registered: Mar 2004
| IP: Logged |
posted
MONDAY, JULY 19, 2004 Independent Study Shows Lifestream Technologies' Cholesterol Monitor to Be as Accurate as Physician's Office Test; Consumers Can Trust Home Test Results - BusinessWire 6:30 AM
POST FALLS, Idaho, Jul 19, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), the leading manufacturer of home cholesterol monitors and professional screening devices, today announced that an independent accuracy and precision study was conducted by Radiant Research, Inc., comparing the Lifestream Cholesterol Monitor against three professional methods: a physician's office lab system, a local independent lab, and the Abell-Kendall method, the US government accuracy and precision standard for all cholesterol test devices.
"It is extremely important that we determine accuracy of at-home testing," stated Dr. Michael Davidson, Medical Director for Radiant Research. "At-home testing provides an opportunity for patients to assume more control of their overall health. If patients can identify the problem early on, they can work with their physician to initiate treatment."
This independent study was conducted at Radiant's Tucson, Arizona, facility under strict scientific controls with trial protocol approved by an Institutional Review Board. The study assessed Lifestream's home cholesterol monitor against an independent lab, a popular physician's office lab system, and the CDC-controlled standard, the Abell-Kendall technique, at a Cholesterol Reference Method Lab. A copy of the study results are available on Lifestream's website at http://www.knowitforlife.com/proresources.asp or by email at gerriv@lifestreamtech.com.
"This study was motivated by recent articles, which implied that results provided by home cholesterol test devices were inaccurate," stated Christopher Maus, Lifestream's President and CEO. "These articles' conclusions, based on non-scientific testing procedures, were assumptive at best and conducted in a casual manner leading the reader to an erroneous conclusion. This journalist approach misleads the public. Although we don't believe any particular media group would intentionally utilize what, in scientific circles, would be considered "junk science," we are trying to reassure the public as to what pure science says about Lifestream's product. The Radiant Research study's conclusions proved that test results obtained with Lifestream's cholesterol monitor were as accurate and precise as the results obtained from a physician's office or an independent lab."
The National Cholesterol Education Program (NCEP) has concluded that home testing can be an important tool in improving adherence to cholesterol programs. Separate studies indicate that as few as 30% of patients remain on statin medication after one year. Home testing has proven to be effective in monitoring blood pressure and glucose; now, it is also effective in cholesterol management programs.
"The results of this preliminary study are clear and unambiguous," stated Jackson Connolly, Lifestream's VP Product Development. "Under strict scientific evaluation protocols and lab practices, the Lifestream Cholesterol Monitor's results prove as accurate as test results received from a physician's office. To further confirm this, a number of other universities are preparing to replicate this study to confirm the results. It is expected that the results of this expanded study will encourage the media to use good journalistic practices relying on scientific literature rather than relying on misleading outcomes from nonscientific methods. We expect the expanded study results to be submitted to important peer review journals."
About Radiant Research
Based near Seattle, Radiant Research (http://www.radiantresearch.com) is a comprehensive clinical research company that provides Phase I-IV clinical drug development services to the biopharmaceutical and medical device industry. Radiant is comprised of more than 50 wholly owned premier clinical research sites nationwide, employing over 1,000 research professionals exclusively focused on providing professional, high-quality comprehensive clinical research services. In the past four years, Radiant has conducted more than 8,400 clinical trials across 18 therapeutic specialties. Radiant's client list includes every major pharmaceutical company and contract research organization and many biotechnology and medical device companies.
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
Posts: 1872 | From: right here | Registered: Apr 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
